Related Experiment Video
Updated: Oct 14, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis
Amirali Karimi1,2, Parnian Shobeiri1,2,3,4, Arutha Kulasinghe5
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
The neutrophil to lymphocyte ratio (NLR) is a robust marker for predicting COVID-19 outcomes, including disease severity and mortality. While other inflammatory markers show promise, NLR remains the most reliable indicator for patient risk stratification.
Area of Science:
- Infectious Diseases
- Immunology
- Critical Care Medicine
Background:
- COVID-19 pandemic caused by SARS-CoV-2 has led to significant global health challenges.
- The disease is characterized by an excessive inflammatory response, impacting patient prognosis.
- Understanding inflammatory markers is crucial for managing COVID-19 patients.
Purpose of the Study:
- To review evidence on 11 groups of systemic inflammatory markers for COVID-19 risk stratification.
- To evaluate the prognostic capabilities of these markers in predicting patient outcomes.
- To compare the effectiveness of various markers against the neutrophil-to-lymphocyte ratio (NLR).
Main Methods:
- Systematic review of studies investigating systemic inflammatory markers in COVID-19 patients.
- Analysis of data on markers such as NLR, SII, PNI, CAR, hsCAR, CPAR, and hsCPAR.
- Comparison of the predictive performance of different markers for COVID-19 prognosis.
Main Results:
- Neutrophil-to-lymphocyte ratio (NLR) effectively prognosticates outcomes like severe disease, hospitalization, ICU admission, intubation, and death.
- Systemic Immune-Inflammation Index (SII), Prognostic Nutritional Index (PNI), CRP to Albumin Ratio (CAR), and CRP to Prealbumin Ratio (CPAR) also demonstrated prognostic value.
- Limited comparative studies exist for markers other than NLR, necessitating larger validation studies.
Conclusions:
- Most studied systemic inflammatory markers can predict COVID-19 prognosis.
- NLR emerges as the most consistently robust marker for assessing COVID-19 patient outcomes.
- Further research is needed to validate the comparative effectiveness of other markers against NLR.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammation
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

